Worth reading
90Important
Scored from 2 of 3 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.The document this correction applies to
Timely disclosureFirst-Quarter Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Non-Consolidated)2025-08-05
What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
87 daysThe pre-correction wording stayed published for this period (Calculated from the Original Disclosure Date Indicated in the Document)
This correction2025-10-31
Location of correction (where in the original document)
添付資料 8 ページ「（３）四半期財務諸表に関する注記事項」内の「セグメント情報等の注記」
Before correction
医薬事業のセグメント利益又は損失（△） △211,807千円 / ヘルスケア事業のセグメント利益又は損失（△） △1,878千円
After correction
医薬事業のセグメント利益又は損失（△） △263,581千円 / ヘルスケア事業のセグメント利益又は損失（△） 49,895千円
Impact on Business Performance (the company’s explanation)
This correction has no impact on earnings.
Reason for correction
「2026 年 3 月期 第１四半期決算短信〔日本基準〕(非連結)」公表後に、記載内容の一部に誤りがあることが判明したため。
| Item | Details |
|---|---|
| Disclosure subject to correction | 2026 年 3 月期 第１四半期決算短信〔日本基準〕(非連結) |
| Original disclosure date | 2025年8月5日 |
| Location of correction | 添付資料 8 ページ「（３）四半期財務諸表に関する注記事項」内の「セグメント情報等の注記」 |
| Details of correction | 医薬事業のセグメント利益又は損失（△） △211,807千円 / ヘルスケア事業のセグメント利益又は損失（△） △1,878千円 → 医薬事業のセグメント利益又は損失（△） △263,581千円 / ヘルスケア事業のセグメント利益又は損失（△） 49,895千円 |
| Reason for correction | 「2026 年 3 月期 第１四半期決算短信〔日本基準〕(非連結)」公表後に、記載内容の一部に誤りがあることが判明したため。 |
| Impact on Business Performance | This correction has no impact on earnings. |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because it was discovered after publication that some of the content contained errors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.